Possible scenario
Pipeline Scrutiny Deepens
20% Chance
Citi's downgrade shifts investor attention from headline trial success to the details of durability, trial design, pricing, and market penetration. The stock becomes more sensitive to any new commentary on oncology timelines and respiratory vaccine uptake.
Tickers
- MRNA-0.6%
Portfolio impact
S&P 500-0.0%
Each figure is the modeled move of the S&P 500 if the outcome occurs. For information only. Not investment advice.
Keeping an eye on this scenario?
Tilt can alert you when its probability or impact shifts, or send you a recommendation when it crosses a threshold.